| Fluoropyrimidine biochemical modulation in colon cancer: pharmacology relevant in both the laboratory and the clinic |
| JH Doroshow and EM Newman |
|
JCO Mar 1 1991: 365–367.
[PDF]
|
 |
| Why should the clonogenic cell assay be prognostically important in ovarian cancer? |
| SA Cannistra |
|
JCO Mar 1 1991: 368–370.
[PDF]
|
|
|
The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer |
| |
JC Marsh, JR Bertino, KH Katz, CA Davis, HJ Durivage, LS Rome, F Richards, 2d, RL Capizzi, LR Farber, and DN Pasquale |
| |
JCO Mar 1 1991: 371–380.
[Abstract]
[PDF]
|
|
|
Clonogenic growth in vitro: an independent biologic prognostic factor in ovarian carcinoma |
| |
C Dittrich, E Dittrich, P Sevelda, M Hudec, H Salzer, T Grunt, and J Eliason |
| |
JCO Mar 1 1991: 381–388.
[Abstract]
[PDF]
|
|
|
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin |
| |
M Markman, R Rothman, T Hakes, B Reichman, W Hoskins, S Rubin, W Jones, L Almadrones, and JL Lewis, Jr |
| |
JCO Mar 1 1991: 389–393.
[Abstract]
[PDF]
|
|
|
Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts |
| |
Z Estrov, R Meir, Y Barak, R Zaizov, and Z Zadik |
| |
JCO Mar 1 1991: 394–399.
[Abstract]
[PDF]
|
|
|
Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia |
| |
EA Schriock, MJ Schell, M Carter, O Hustu, and JJ Ochs |
| |
JCO Mar 1 1991: 400–405.
[Abstract]
[PDF]
|
|
|
Percutaneous needle biopsy preceding preoperative chemotherapy in the management of massive renal tumors in children |
| |
UM Saarinen, S Wikstrom, O Koskimies, and H Sariola |
| |
JCO Mar 1 1991: 406–415.
[Abstract]
[PDF]
|
|
|
A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia |
| |
VM Santana, J Mirro, Jr, FC Harwood, J Cherrie, M Schell, D Kalwinsky, and RL Blakley |
| |
JCO Mar 1 1991: 416–422.
[Abstract]
[PDF]
|
|
|
Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high- dose cytarabine, and cisplatin before marrow transplantation |
| |
OW Press, R Livingston, J Mortimer, C Collins, and F Appelbaum |
| |
JCO Mar 1 1991: 423–431.
[Abstract]
[PDF]
|
|
|
Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study |
| |
G Cimino, G Papa, S Tura, P Mazza, PL Rossi Ferrini, A Bosi, S Amadori, F Lo Coco, E D'Arcangelo, and D Giannarelli |
| |
JCO Mar 1 1991: 432–437.
[Abstract]
[PDF]
|
|
|
The pattern of intrathoracic Hodgkin's disease assessed by computed tomography |
| |
LF Diehl, KD Hopper, J Giguere, E Granger, and M Lesar |
| |
JCO Mar 1 1991: 438–443.
[Abstract]
[PDF]
|
|
|
Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients |
| |
M Boccadoro, F Marmont, M Tribalto, G Avvisati, A Andriani, T Barbui, M Cantonetti, M Carotenuto, B Comotti, and F Dammacco |
| |
JCO Mar 1 1991: 444–448.
[Abstract]
[PDF]
|
|
|
Inhibition of fluorouracil-induced stomatitis by oral cryotherapy |
| |
DJ Mahood, AM Dose, CL Loprinzi, MH Veeder, LM Athmann, TM Therneau, JM Sorensen, DK Gainey, JA Mailliard, and NL Gusa |
| |
JCO Mar 1 1991: 449–452.
[Abstract]
[PDF]
|
|
|
Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: a Southwest Oncology Group study |
| |
GE Goodman, J Crowley, RB Livingston, SE Rivkin, K Albain, and JH McCulloch |
| |
JCO Mar 1 1991: 453–457.
[Abstract]
[PDF]
|
|
|
Concurrent cisplatin, infusional fluorouracil, and conventionally fractionated radiation therapy in head and neck cancer: dose-limiting mucosal toxicity |
| |
JW Denham and RL Abbott |
| |
JCO Mar 1 1991: 458–463.
[Abstract]
[PDF]
|
|
|
Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration |
| |
LG Feun, R Gonzalez, N Savaraj, J Hanlon, M Collier, WA Robinson, and NJ Clendeninn |
| |
JCO Mar 1 1991: 464–467.
[Abstract]
[PDF]
|
|
|
Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice: a novel experimental model of three concomitant paraneoplastic syndromes |
| |
T Yoneda, TB Aufdemorte, R Nishimura, N Nishikawa, M Sakuda, MM Alsina, JB Chavez, and GR Mundy |
| |
JCO Mar 1 1991: 468–477.
[Abstract]
[PDF]
|
|
|
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide |
| |
DA Scheinberg, D Lovett, CR Divgi, MC Graham, E Berman, K Pentlow, N Feirt, RD Finn, BD Clarkson, and TS Gee |
| |
JCO Mar 1 1991: 478–490.
[Abstract]
[PDF]
|
|
|
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine |
| |
JL Abbruzzese, R Grunewald, EA Weeks, D Gravel, T Adams, B Nowak, S Mineishi, P Tarassoff, W Satterlee, and MN Raber |
| |
JCO Mar 1 1991: 491–498.
[Abstract]
[PDF]
|
|
|
Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung |
| |
RJ Klasa, N Murray, and AJ Coldman |
| |
JCO Mar 1 1991: 499–508.
[Abstract]
[PDF]
|
|
|
Bone metastases: pathophysiology and management policy |
| |
OS Nielsen, AJ Munro, and IF Tannock |
| |
JCO Mar 1 1991: 509–524.
[Abstract]
[PDF]
|
|
| Quality-adjusted survival analysis |
| JE Till and JC de Haes |
|
JCO Mar 1 1991: 525–526.
[PDF]
|
|
| Chemotherapy, tamoxifen, and breast cancer: reconciling differences |
| H Pourquier |
|
JCO Mar 1 1991: 526–528.
[PDF]
|
|
| Treatment of childhood Hodgkin's disease |
| H Ekert |
|
JCO Mar 1 1991: 528–529.
[PDF]
|
|
| Cyclophosphamide and the heart |
| BH Kushner and NK Cheung |
|
JCO Mar 1 1991: 529–530.
[PDF]
|
|
